ICL vs BGM vs GRO Stock Comparison

Icl, Bgm and Brazil Potash Prices as of Oct 26, 2026 Peers: Industry group
ICL ICL Group Ltd.
$4.81 -6.4% 1M -26.7% 1Y
Market cap
$6.40B
P/E
9.3x
Revenue (TTM)
$7.71B
Div. yield
–
Fertilizers Basic Materials
3 wins
BGM BGM Group Ltd.
$8.40 +3,400.0% 1M -10.1% 1Y
Market cap
$32.28M
P/E
–
Revenue (TTM)
—
Div. yield
–
Generic Drugs Healthcare
1 win
GRO Brazil Potash Corp.
$1.69 -28.4% 1M -33.2% 1Y
Market cap
$76.70M
P/E
–
Revenue (TTM)
—
Div. yield
–
Fertilizers Basic Materials

Head to Head

4 decided of 12

Icl leads on 3 of the 12 questions below (Icl 3, Bgm 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionICLBGMGROLeader
Larger companyMarket capitalisation $6.40B $32.28M $76.70M ICL
Cheaper on earningsLower P/E, profitable companies only 9.3x — -0.9x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 12.0x — — –
Faster revenue growthRevenue growth, trailing twelve months +10.9% — — –
More profitableNet margin, trailing twelve months 9.0% — — –
Better return on capitalReturn on invested capital — — — –
Less leveragedLower net debt / EBITDA — — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -26.7% -10.1% -33.2% BGM
Better 5-year returnAnnualised price return, 5 years -11.0%/yr — — –
Less volatileAnnualised volatility, 1 year 39.0% 380.3% 78.7% ICL
Higher overall scoreMean of the five percentile scores vs peers 82/100 — 33/100 ICL

Percentile Scorecard

ICLBGMGRO

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisICLBGMGRO
Valuation 98 #3 of 94 – 12 #83 of 94
Growth 47 #49 of 92 – 53 #44 of 92
Profitability 82 #17 of 89 – 6 #84 of 89
Financial Health – 60 #264 of 658 93 #8 of 97
Shareholder Returns 100 #1 of 70 – 0 #70 of 70
Overall 82 – 33
  • ICL ranked among 99 companies in Chemicals
  • BGM ranked among 673 companies in Pharmaceuticals and Biotechnology
  • GRO ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodICLBGMGROSPY
1 month -6.4%+3,400.0%-28.4% -0.8%
3 months -6.8%+2,700.0%-17.6% +3.5%
6 months -13.2%+2,413.5%-50.7% +7.0%
Year to date -15.8%+127.6%-10.6% +12.2%
1 year -26.7%-10.1%-33.2% +13.0%
3 years 0.0%—— +86.3%
3 years, per year 0.0%—— +23.1%
5 years -44.1%—— +68.6%
5 years, per year -11.0%—— +11.0%
10 years +30.7%—— +258.0%
10 years, per year +2.7%—— +13.6%

Risk

MeasureICLBGMGROSPY
Volatility, 1Y 39.0%380.3%78.7% 12.7%
Downside volatility, 1Y 44.8%158.2%79.2% 12.7%
Beta vs S&P 500, 1Y 0.771.731.55 1.00
Return / volatility, 1Y -0.68-0.03-0.42 1.02
Max drawdown, 5Y -70.0%-98.5%-90.5% -25.4%
From 52-week high -29.5%-21.9%-56.6% -1.8%
52-week high $6.82$10.75$3.89 $779.14
52-week low $4.70$0.24$1.69 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleICLBGMGRO
P/E now vs peer median 9.0xmedian 21.6x —median 17.1x -0.8xmedian 21.6x
P/S now vs peer median 0.8xmedian 1.4x —median 8.8x —median 1.4x
EV/EBITDA now vs peer median —median 12.4x —median 17.1x —median 12.4x
P/FCF now vs peer median 5.2xmedian 15.8x —median 18.0x -3.7xmedian 15.8x
P/B now vs peer median —median 1.6x 0.1xmedian 2.1x 0.4xmedian 1.6x
PEG now vs peer median -0.55median 1.66 —median 0.31 —median 1.66

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsICLBGMGRO
Revenue $7.71B – –
Gross profit $2.36B – –
Operating income $715.00M – -$95.57M
Net income $654.00M – -$28.15M
Free cash flow $1.19B – -$24.85M
EPS (diluted) $0.54 – $-2.04
Cash & equivalents $496.00M $11.52M $75.71M
Total debt – $8.25M –
Shares (diluted) 1.29B 3.78M 42.49M
Enterprise value $3.10B -$22.76M -$58.61M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricICLBGMGRO
P/E 9.0x – -0.8x
P/FCF 5.2x – -3.7x
P/Operating cash flow – – -7.2x
P/S 0.8x – –
P/B – 0.1x 0.4x
P/Tangible book – 0.1x 0.4x
EV/EBITDA – – –
EV/EBIT 8.0x – -0.2x
EV/Revenue 0.7x – –
EV/FCF 4.8x – -0.6x
EV/Operating cash flow – – -1.2x
PEG (3Y EPS CAGR) -0.55 – –

Growth

14 metrics
MetricICLBGMGRO
Revenue growth (1Y) 10.9% – –
Revenue CAGR (3Y) 1.8% – –
Gross profit growth (1Y) 5.2% – –
Gross profit CAGR (3Y) 5.2% – –
Operating income growth (1Y) -1.7% – -3.3%
Operating income CAGR (3Y) -20.8% – –
Net income growth (1Y) -1.7% – 57.9%
Net income CAGR (3Y) -18.0% – –
EPS growth (1Y) 88.4% – 27.7%
EPS CAGR (3Y) -16.4% – –
Operating cash flow growth (1Y) – – 20.5%
Operating cash flow CAGR (3Y) – – –
Free cash flow growth (1Y) -17.5% – -1.1%
Free cash flow CAGR (3Y) -8.0% – –

Profitability

14 metrics
MetricICLBGMGRO
Gross margin 30.6% – –
EBITDA margin – – –
Operating margin 9.3% – –
Pretax margin 9.9% – –
Net margin 9.0% – –
FCF margin 15.4% – –
Operating cash flow margin – – –
Return on equity – – -47.7%
Return on assets – – -43.5%
Return on invested capital – – –
Return on capital employed – – -48.5%
Asset turnover – – –
Cash conversion (OCF / net income) – – 0.4x
Stock comp / revenue – – –

Financial Health

11 metrics
MetricICLBGMGRO
Debt / assets – 0.2% –
Debt / equity – 0.0x –
Net debt / EBITDA – – –
Debt / FCF – – –
Liabilities / assets – 8.4% 5.4%
Equity / assets – 91.6% 94.6%
Interest coverage – – -94.7x
Current ratio – 1.3x 42.2x
Quick ratio – 0.4x 41.9x
Cash ratio – 0.3x 41.8x
Altman Z-score – – –

Shareholder Returns

7 metrics
MetricICLBGMGRO
Dividend yield 13.1% – –
Net buyback yield – – -69.7%
Shareholder yield 13.1% 0.0% -69.7%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusICLBGMGRO
Forward P/E 12.0xFY2026 – –
EPS, next fiscal year $0.40FY2026 – $-0.49FY2026
EPS growth, next FY +11.1%FY2026 – –
EPS growth, the year after +12.5% – –
Revenue, next fiscal year $7.47BFY2026 – $0.00FY2026
Revenue growth, next FY +4.5%FY2026 – –
Revenue growth, the year after +13.0% – –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersICLBGMGRO
Held by institutions 13.7% – –
Institutions holding 221 – –
Change in shares held, QoQ -13.5% – –
Institutions buying 140 – –
Institutions selling 56 – –
Buyers to sellers 2.50 – –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ICLBGMGRO
ICL 1.00 -0.01 0.20
BGM -0.01 1.00 -0.02
GRO 0.20 -0.02 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ICL, BGM and GRO?

Icl (ICL) is the largest by market capitalisation: Icl (ICL) $6.40B, Bgm (BGM) $32.28M, Brazil Potash (GRO) $76.70M.

Which stock has performed better?

Over the past year Bgm (BGM) returned the most: Icl (ICL) -26.7%, Bgm (BGM) -10.1%, Brazil Potash (GRO) -33.2%. Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Icl (ICL) has been the steadiest (Icl (ICL) 39.0%, Bgm (BGM) 380.3%, Brazil Potash (GRO) 78.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ICL, BGM and GRO?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Icl (ICL) leads on 3. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.